Skip to search formSkip to main contentSkip to account menu
You are currently offline. Some features of the site may not work correctly.

Anzatax

National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Paclitaxel

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Targeted Nanostructured Lipid Carriers for Delivery of Paclitaxel to Cancer Cells: Preparation, Characterization, and Cell Toxicity.
OBJECTIVE Low water solubility, high systemic toxicity and insignificant cellular uptake have limited efficient clinical… 
2016
2016
In vivo pharmacokinetics, biodistribution and anti-tumor effect of paclitaxel-loaded targeted chitosan-based polymeric micelle
Abstract A water-insoluble anti-tumor agent, paclitaxel (PTX) was successfully incorporated into novel-targeted polymeric… 
2016
2016
Non-invasive endotracheal delivery of paclitaxel-loaded alginate microparticles
Aerosolized chemotherapeutics leads to higher, localized and continuous concentrations of active agents in lung tissue with lower… 
2015
2015
Development and in vitro/in vivo evaluation of a novel targeted polymeric micelle for delivery of paclitaxel.
In this study a novel receptor-targeted micelle delivery system based on tocopherol succinate-chitosan-polyethylene glycol-folic… 
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • table 1
2015
2015
A Rapid and Sensitive HPLC Method for Quantitation of Paclitaxel in Biological Samples using Liquid-Liquid Extraction and UV Detection: Application to Pharmacokinetics and Tissues Distribution Study…
A simple, rapid, and sensitive reversed-phase HPLC method was developed and validated for determination of paclitaxel (PTX) in… 
2008
2008
The clinical study of combined chemotherapy based on anzatax and cisplatin in the treatment of non-small cell lung cancer
Objective:To observe the efficacy,tolerance and adverse effect of anzatax and cisplatin combined chemotherapy in the treatment of… 
2001
2001
Salvage therapy with single-agent paclitaxel by three-hour infusion in metastatic breast cancer: an experience in Taipei Veterans General Hospital.
BACKGROUND Paclitaxel is an active agent in the treatment of breast, ovarian, lung and head and neck cancers. In previous phase I… 
  • table 1
  • table 2
  • table 3
  • table 4
Highly Cited
1998
Highly Cited
1998
Activity of paclitaxel by three-hour infusion in Asian patients with metastatic undifferentiated nasopharyngeal cancer.
  • E. Au, E. Tan, P. Ang
  • Annals of oncology : official journal of the…
  • 1998
  • Corpus ID: 22841078
BACKGROUND Despite its moderate anti-tumour activity in head and neck cancers there have been no reports on the activity of… 
1997
1997
Australian multicentre phase II trial of paclitaxel in women with metastatic breast cancer and prior chemotherapy
To determine the efficacy and safety of paclitaxel given as a three‐hour infusion in patients with metastatic breast cancer which… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE